New Drug May Brighten Outlook for Advanced Breast Cancer

WEDNESDAY, Nov. 16, 2016 — A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms.
The drug, called palbociclib (Ibrance), was approved in the United States last year for treating advanced…
Source: Topamax